Bayer Property, Plant, and Equipment 2010-2024 | BAYRY

Bayer property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Bayer Annual Property, Plant, and Equipment
(Millions of US $)
2023 $14,417
2022 $14,407
2021 $15,011
2020 $13,376
2019 $13,976
2018 $15,287
2017 $8,628
2016 $14,512
2015 $13,741
2014 $15,191
2013 $13,303
2012 $12,685
2011 $13,681
2010 $13,060
2009 $13,122
Bayer Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-06-30 $14,524
2024-03-31 $14,627
2023-12-31 $14,417
2023-09-30 $14,638
2023-06-30 $14,368
2023-03-31 $14,289
2022-12-31 $14,407
2022-09-30 $14,021
2022-06-30 $14,127
2022-03-31 $14,348
2021-12-31 $15,011
2021-09-30 $14,193
2021-06-30 $14,254
2021-03-31 $14,238
2020-12-31 $13,376
2020-09-30 $13,446
2020-06-30 $13,048
2020-03-31 $13,352
2019-12-31 $13,976
2019-09-30 $14,536
2019-06-30 $15,386
2019-03-31 $15,826
2018-12-31 $15,287
2018-09-30 $16,206
2018-06-30 $16,413
2018-03-31 $9,010
2017-12-31 $8,628
2017-09-30 $14,574
2017-06-30 $13,938
2017-03-31 $12,848
2016-12-31 $14,512
2016-09-30 $13,838
2016-06-30 $13,809
2016-03-31 $13,159
2015-12-31 $13,741
2015-09-30 $13,183
2015-06-30 $13,134
2015-03-31 $13,656
2014-12-31 $15,191
2014-09-30 $14,093
2014-06-30 $13,802
2014-03-31 $13,652
2013-12-31 $13,303
2013-09-30 $13,063
2013-06-30 $12,999
2013-03-31 $13,279
2012-12-31 $12,685
2012-09-30 $12,134
2012-06-30 $12,543
2012-03-31 $12,494
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $0.000B $51.553B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $710.098B 73.55
Novo Nordisk (NVO) Denmark $471.460B 34.00
Johnson & Johnson (JNJ) United States $373.591B 15.15
AbbVie (ABBV) United States $312.696B 16.46
Merck (MRK) United States $250.889B 16.67
Novartis AG (NVS) Switzerland $213.148B 14.17
AstraZeneca (AZN) United Kingdom $203.493B 17.32
Pfizer (PFE) United States $145.358B 9.94
Sanofi (SNY) $122.526B 11.10
Innoviva (INVA) United States $1.199B 9.97